6
Oct
2026

Inke S.A.

Exhibitor at CPHI Milan 2026 stand 4C57, API
About Us

Inke S.A., based in Barcelona, Spain, specializes in high-quality Active Pharmaceutical Ingredients (APIs) with complex synthesis, focusing primarily on respiratory applications. With over 20 years in micronization and a global reach spanning the US, Europe, and Japan, Inke develops and patents its own synthesis routes. We also offer Contract Manufacturing Organization (CMO) services, providing customized micronization solutions. Inke has been inspected by major regulatory authorities, including a successful FDA inspection in 2019. To learn more, contact us at [email protected]

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Spain
  • On CPHI since:
    2017
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Other
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 4C57, API

Products Featured at CPHI Milan 2026

  • Aclidinium bromide

    Product Aclidinium bromide

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aclidinium. Indication: COPD treatment
  • Aprepitant

    Product Aprepitant

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aprepitant. Indication: Emesis

  • Arformoterol tartrate polymorph A and D

    Product Arformoterol tartrate polymorph A and D

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Arformoterol tartrate. Indication for COPD 

    US and CN DMF available
  • Asenapine maleate

    Product Asenapine maleate

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Asenapine. Indications: Schizophrenia and acute mania

  • Carvedilol

    Product Carvedilol

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Carvedilol. Indications: hypertension, angina and heart failure


    JP DMF available

Inke S.A. Resources (1)

  • INKE PORTFOLIO AND PIPELINE

    Brochure INKE PORTFOLIO AND PIPELINE

    Inke is a Barcelona-based company with an FDA approved plant, we develop and manufacture APIs with complex synthesis process mostly for Respiratory diseases (Inhalation) and also CNS , among other therapeutically areas.

     
    INKE has several DMFs approved already in the US-FDA and we are already supplying to some local and multinational pharmaceutical companies worldwide.